NHS National Generic Pharmaceuticals Wave 13
Details
- Buyer
- Home Office
- Supplier(s)
99 suppliers
- AVENTIS PHARMA LIMITED
- Accord UK Ltd
- ACIUM LTD
- Aguettant Ltd
- Alissa Healthcare Research Limited
- Allergan Limited
- Alliance Pharmaceuticals Ltd
- Altan Pharma Ltd
- Amarox Ltd
- AOP Orphan Ltd
- Arcadia Pharma Limited T/A Arcadia Medical
- Aristo Pharma Ltd
- Ascend Laboratories (UK) Limited
- Aspen Pharmacare UK Limited
- Aspire Pharma Ltd
- B. BRAUN MEDICAL LIMITED
- Baxter Healthcare Ltd
- Bayer Ltd
- Bowmed Ibisqus Ltd
- Bristol Laboratories Ltd
- Brown and Burk
- Cipla (EU) Ltd
- Colonis Pharma Limited
- Consilient Health Ltd
- Crescent Pharma Limited
- CST Pharma Limited
- Day Lewis Medical Ltd
- Derma UK
- Desitin Pharma Ltd
- Dexcel Pharma Ltd
- Dr Falk Pharma UK Ltd
- Dr Reddy's Laboratories (UK) Ltd
- DRUGSRUS LIMITED
- Ennogen HealthCare
- Ferring Pharmaceutical
- Flexipharm Austrading Ltd
- Fontus Health Ltd
- FRESENIUS KABI LIMITED
- GLAXOSMITHKLINE UK LIMITED
- Glenmark Pharmaceuticals Europe Ltd
- Hameln Pharma Ltd
- Healthcare Pharma Ltd
- Kensington Pharma Ltd
- Kent Pharma Ltd
- Kyowa Kirin Ltd
- Laboratorio Reig Jofre SA
- LEO Pharma
- LogixX Pharma Ltd
- Lucane Pharma
- Lundbeck Limited
- Lupin Healthcare (UK) Ltd
- Macleods Pharma UK Limited
- Macure Pharma ApS
- Manx Healthcare Ltd
- Martindale Pharma
- medac Pharma LLP
- Medreich Plc
- MERCK SHARP & DOHME (UK) LIMITED
- Mercury Pharmaceuticals Ltd
- Milpharm Ltd/aurobinbdo
- MIP Pharma GmbH
- Morningside Pharmaceuticals Ltd
- Mylan
- Napp Pharmaceuticals Ltd
- Neon Healthcare Ltd
- Nexcape Pharmaceuticals Ltd
- Norgine Pharmaceuticals Limited
- Organon Pharmaceuticals UK Ltd
- Panpharma UK Ltd
- PARI
- Pfizer Liimted
- Pierre Fabre Ltd
- Profile Pharma Ltd
- Ranbaxy UK
- Reckitt Benckiser
- Recordati Rare Diseases UK Ltd
- RELONCHEM LIMITED
- Rivopharm
- Roche Products Ltd
- Roma Pharmaceuticals Limited
- Rosemont Pharmaceuticals Ltd
- RPH Pharmaceuticals AB
- Sandoz
- Seacross Pharmaceuticals Ltd
- Selective Supplies Ltd
- Stragen UK Ltd
- Strides Pharma Uk LTD
- Synchrony
- Syri Limited (T/A Thame Laboratories)
- Teva UK Ltd
- Thea Pharmaceuticals Ltd
- Thornton and Ross
- Torbay Pharmaceuticals
- Torrent Pharma (UK) Ltd
- V Pharma
- Waverley Pharma Europe Ltd
- Wockhardt UK Limited
- Zentiva Pharma UK Ltd
- Zista Pharma Ltd
- Value
- £469,741,550
- Duration
- 3 years
- Topic
- Pharmaceutical products
- Published
- 20 January 2022
- Source
- uk:contracts_finder
Tender description
Invitation to offer for NHS National Generic Pharmaceuticals Wave 13 Offer reference number: CM/PHG/17/5532 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority's sole discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Transition (Everolimus) CESW: 1 March 2022 - 30 September 2023 (19 months) LSNE: 1 March 2022 - 31 January 2023 (11 months) NWLN: 1 March 2022 - 31 January 2023 (11 months) Oral Products plus non-parenterals All Regions: 1 March 2022 - 31 May 2024 (27 months) Hospital Only Products CESW: 1 February 2022 - 30 September 2023 (20 months) LSNE: 1 February 2022 - 31 May 2024 (28 months) NWLN: 1 February 2022 - 31 January 2023 (12 months)
Timeline
- Completed: Award date30 November 2021
- Completed: Award published20 January 2022Current notice
- Completed: Contract expiry date31 May 2024
About the buyer
Home Office is a central ministerial department, and it buys through its own commercial and procurement function. Border Force, UK Visas and Immigration and HM Passport Office sit within the department. Procurement opportunities are published on the Find a Tender Service, alongside commercial pipeline notices for work still ahead of formal tender. Many IT and digital contracts are advertised through Crown Commercial Service framework agreements. The Jaggaer eSourcing Portal handles the department's tendering activity for suppliers and procurement professionals. Security-sector contracts run through the Joint Security and Resilience Centre, a dedicated procurement route for that work.
Procurement spend from central entities makes up 66% of overall UK public spend.
Over the past 5 years, most of Home Office's contract awards have been in IT services, business services and software and information systems.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@home-office.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@home-office.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@home-office.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@home-office.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@home-office.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@home-office.gov |
14 similar open tenders
See more open tenders related to NHS National Generic Pharmaceuticals Wave 13.
- Open tender
Generic Drugs - Injections/Infusions
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
Related buyers
Buyers similar to Home Office.
- 1,718£67.6bn
- 860£126.5bn
- 814£1.4bn
- 681£160.4bn
- 395£11.5bn
- 391£1.6bn
- 321£1.5bn
- 295£1.7bn
- 285£671.8m
- 222£221.9bn
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
